- Camfetamine
- CFA
Welter-Luedeke, J; Maurer, HH. New psychoactive substances: chemistry, pharmacology, metabolism, and detectability of amphetamine derivatives with modified ring systems Ther. Drug Monit., 1 Feb 2016, 38 (1), 4–11. 216 kB. https://doi.org/10.1097/FTD.0000000000000240 #CFA
EMCDDA. New drugs in Europe, 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Apr 2012. 401 kB.
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #Camfetamine
Kavanagh, PV; Angelov, D; O’Brien, J; Power, JD; McDermott, SD; Talbot, B; Fox, J; O’Donnell, C; Christie, R. The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™) Drug Test. Anal., 1 Apr 2013, 5 (4), 247–253. 1.1 MB. https://doi.org/10.1002/dta.411 #5 MS,NMR,IR,other